Psychopharmacology and Psychiatry Updates
En podkast av Psychopharmacology Institute
Kategorier:
265 Episoder
-
Tips for Treating Perimenopausal Depression
Publisert: 28.11.2021 -
Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder
Publisert: 23.11.2021 -
Subclinical Hypothyroidism in Depressed Adolescents
Publisert: 18.11.2021 -
Principles for Managing Alcohol Use Disorder
Publisert: 13.11.2021 -
ECT for Depressed Patients With Borderline Personality Disorder
Publisert: 8.11.2021 -
Assessing and Treating Alcohol Withdrawal
Publisert: 3.11.2021 -
Lab Tests in Psychopharmacology
Publisert: 29.10.2021 -
Technology-Facilitated Adherence Enhancement and Family Involvement
Publisert: 24.10.2021 -
Drug-Induced Hyperthermic Syndromes in Psychiatry
Publisert: 19.10.2021 -
How to Improve Adherence: Targeting Reasons for Nonadherence
Publisert: 14.10.2021 -
Esketamine: Postmarketing Safety Concerns
Publisert: 9.10.2021 -
Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER
Publisert: 4.10.2021 -
Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19
Publisert: 29.9.2021 -
How to Assess Psychotropic Drug Adherence
Publisert: 24.9.2021 -
Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)
Publisert: 19.9.2021 -
Delirium, Catatonia, and COVID-19
Publisert: 14.9.2021 -
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Publisert: 9.9.2021 -
Dopamine and Depression: Clinical Considerations
Publisert: 4.9.2021 -
Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium
Publisert: 30.8.2021 -
New Somatic Treatments for Child and Adolescent Depression
Publisert: 25.8.2021
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
